FDA places clinical hold on Regeneron and Teva’s pain drug trial
The drug is being developed and commercialized jointly by Regeneron Pharmaceuticals and Teva Pharmaceutical Industries. Under a separate deal with Regeneron, Mitsubishi Tanabe Pharma has exclusive development and